ÂÜÀòÂÒÂ×

Peter Ellman is the President and CEO of Certis Oncology Solutions, a precision oncology and translational science start-up established in 2016 and located in San Diego, California.

A serial entrepreneur, prior to his current role Peter led Paradox Dx, a pharmacogenomics business and Nextec Applications, an advanced materials technology company. He served on the board of StrataGene, a publicly held molecular diagnostics company acquired by Agilent in 2007. He also served as founding sales executive for Thermoscan, the world’s first infra-red ear thermometer acquired by Gillette in 2003 and Interplak, an electronic consumer products company acquired by Bausch and Lomb in 1988.